Fritextsökning
Artiklar per år
Innehållstyper
-
Linköpingsforskare ska studera samband mellan vanligt läkemedel och benbrott
Det oroväckande sambandet mellan ett vanligt läkemedel mot benskörhet och ökad risk för en viss typ av benbrott ska studeras i ett internationellt forskningsprojekt. Linköpingsforskaren Jörg Schilcher leder en del av arbetet med hjälp av anslag från amerikanska myndigheter.
-
Individual DNA passport could result in fewer drug side effects
You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer side effects if the drug treatment is adapted to their genes.
-
Eugen Steiner föreslås bli styrelseordförande i Bioarctic
Läkaren och styrelseproffset Eugen Steiner föreslås ta över som ordförande i Bioarctic efter avgående Wenche Rolfsen.
-
Claims of life science companies fleeing abroad is a myth according to survey
The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.
-
Precision medicine centre: “Extensive activity on several fronts”
Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech Magazine called Anna Wedell, who is heading the work, to find out…
-
KI-studie: CAR-T visade effekt mot äggstockscancer hos möss
Idag finns inga fungerande CAR-T-terapier mot solida tumörer. Men nu har forskare vid Karolinska institutet nått lovande resultat i studier med möss med äggstockscancer.
-
Column: ”We need to exploit the benefits of the regulations“
You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good conditions for growing new solutions, but it is also becoming increasingly clear that we are challenged in one area – regulations, writes Björn Arvidsson in a column.
-
Självadministrerad astmabehandling godkänd i USA
Astra Zeneca tillsammans med det amerikanska företaget Amgen har nu fått det självadministrerade astmaläkemedlet Tezspire godkänt i USA.
-
The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time
According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the previous year. In a bill presented by the government a number of proposals are put forward to counteract the problem.
-
He saved lives with his theories – was ostracised and ended up in a mental hospital
Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with luck and timing.
-
"Unclear proposal from the EU Commission on how to solve the MDR challenges"
Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the availability of medical devices in the EU. Unfortunately, the fears have come true.
-
Immunovia rekryterar från Roche
Cancerdiagnostikföretaget Immunovia har anställt Lara E Sucheston-Campbell som ansvarig för kliniska och medicinska ärenden, eller Head of Medical and Clinical Affairs.
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including heading the production of the company’s Covid vaccine, he is now advancing to the absolute top.
-
Bioarctics Alzheimerläkemedel godkänt i USA
Alzheimerläkemedlet lecanemab godkänns i USA. Beskedet på fredagen är en fullträff för svenska Bioarctic som stått för den tidiga utvecklingen av preparatet.
-
Sweden is organising a large life science conference as part of the EU presidency
On 26-27 June, Sweden will host a European meeting on life science.
-
“Everyone is screaming for talent”
Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Horizons in Biologics & Bioprocessing conference on 15 December.
-
Sobis behandling mot B-cellslymfom godkänd i EU
EU-kommissionen har lämnat ett villkorligt godkännande för Zynlonta som behandling av svårbehandlade former av diffust stort B-cellslymfom (DLBCL).
-
Sverige arrangerar stor life science-konferens som del av EU-ordförandeskapet
Den 26-27 juni ska Sverige stå värd för ett europeisk möte om life science, berättar Jenni Nordborg, nationell life science-samordnare.
-
Jacob Lund blir global presschef för Astra Zeneca
Astrazeneca flyttar upp Jacob Lund till rollen som global presschef. Han är idag bolagets kommunikationsdirektör i Norden.
-
Vaccin mot denguefeber har fått godkänt av EU
Efter att Takedas vaccin mot denguefeber –Qdenga – blivit godkänt i EU hoppas nu företaget på att det ska bana väg för fler godkännande världen över.
-
Nytt KI-centrum ska lösa gåtan kring världens värsta huvudvärk
Karolinska institutet startar vad som uppges vara världens första forskningscentrum för klusterhuvudvärk, som är den mest smärtsamma huvudvärk som finns.
-
ALS – When the body has given up, but the brain persists
The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and with the help of, among other things, a Swedish-developed invention, communication with the outside world can continue. “It’s their window to the world,” says ALS researcher Caroline Ingre.
-
“Photon counting in computed tomography is the holy grail”
Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation dose in patients, he is setting out to develop a framework for virtual clinical trials for the technology.
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered by us one of the most important contemporary Swedish innovations in the field of medicine.